Ewing Sarcoma Treatment at Medical City Dallas

Due to the small number of children and adolescents with cancer, new drugs for this population are often an afterthought for new drug development. Mary Crowley wants to play a role in changing this afterthought to a forethought, initially by focusing on Ewing's Sarcoma, an aggressive, malignant tumor of bone and soft tissue most commonly occurring in children, adolescents and young adults. Two thirds of children diagnosed with advanced Ewing sarcoma will not survive with current treatments. The FDA has granted approval for Mary Crowley, based on their prior adult results, to expand the Phase 1 FANG™ personalized vaccine clinical trial for Ewing sarcoma patients.